• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Nat Commun . A(H2N2) and A(H3N2) influenza pandemics elicited durable cross-reactive and protective antibodies against avian N2 neuraminidases

tetano

Editor, Senior Moderator
Nat Commun


. 2024 Jul 3;15(1):5593.
doi: 10.1038/s41467-024-49884-9. A(H2N2) and A(H3N2) influenza pandemics elicited durable cross-reactive and protective antibodies against avian N2 neuraminidases

Zaolan Liang[SUP] 1 2 3 [/SUP], Xia Lin[SUP] 1 2 3 [/SUP], Lihong Sun[SUP] 4 [/SUP], Kimberly M Edwards[SUP] 1 2 [/SUP], Wenjun Song[SUP] 5 [/SUP], Hailiang Sun[SUP] 6 [/SUP], Yanmin Xie[SUP] 7 [/SUP], Fangmei Lin[SUP] 3 [/SUP], Shiman Ling[SUP] 3 [/SUP], Tingting Liang[SUP] 3 [/SUP], Biying Xiao[SUP] 3 [/SUP], Jiaqi Wang[SUP] 3 [/SUP], Min Li[SUP] 1 2 [/SUP], Chin-Yu Leung[SUP] 1 2 [/SUP], Huachen Zhu[SUP] 8 9 [/SUP], Nisha Bhandari[SUP] 10 [/SUP], Raghavan Varadarajan[SUP] 10 [/SUP], Min Z Levine[SUP] 11 [/SUP], Malik Peiris[SUP] 2 12 [/SUP], Robert Webster[SUP] 13 [/SUP], Vijaykrishna Dhanasekaran[SUP] 1 2 [/SUP], Nancy H L Leung[SUP] 7 14 [/SUP], Benjamin J Cowling[SUP] 7 14 [/SUP], Richard J Webby[SUP] 13 [/SUP], Mariette Ducatez[SUP] 15 [/SUP], Mark Zanin[SUP] 16 17 [/SUP], Sook-San Wong[SUP] 18 19 [/SUP]



Affiliations
Abstract

Human cases of avian influenza virus (AIV) infections are associated with an age-specific disease burden. As the influenza virus N2 neuraminidase (NA) gene was introduced from avian sources during the 1957 pandemic, we investigate the reactivity of N2 antibodies against A(H9N2) AIVs. Serosurvey of healthy individuals reveal the highest rates of AIV N2 antibodies in individuals aged ≥65 years. Exposure to the 1968 pandemic N2, but not recent N2, protected against A(H9N2) AIV challenge in female mice. In some older adults, infection with contemporary A(H3N2) virus could recall cross-reactive AIV NA antibodies, showing discernable human- or avian-NA type reactivity. Individuals born before 1957 have higher anti-AIV N2 titers compared to those born between 1957 and 1968. The anti-AIV N2 antibodies titers correlate with antibody titers to the 1957 N2, suggesting that exposure to the A(H2N2) virus contribute to this reactivity. These findings underscore the critical role of neuraminidase immunity in zoonotic and pandemic influenza risk assessment.


 
Back
Top Bottom